| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Apr3g0276 | ATGTTCCTTCTTAGAAGGCAAAGCCAGAATCAGCAGGAGAATGATTCCTCGTATCAAGATACAAAGGTGGCTGAACTCAGAGCTGCTCTTGGGCCCCTCTCTGGTCGTCGATTGAAGTATTGCACAGATGCATGTCTGAGGCGATATTTAGAAGCAAGGAACTGGAATGTTGATAAAGCCAAGAAAATGCTGGAGGAAACACTCAAGTGGAGGTCAACTTATAAGCCAGAGGAAATCCAATGGGCTGAAGTAGCACATGAGGGTGAGACGGGCAAAGTCTCAAGAGCTAACTTTCATGATCGACTTGGGAGGACTGTGCTTATTATGAGGCCAGGGATGCAGAACACGGCATCAGCTGAAAATAATATCAGGCATTTAGTCTATCTGTTGGAAAATGCTGTCCTAAATCTTTCTGAAGGTCAAGAACAAATGTCATGGTTGATAGACTTCACAGGATTTACGCTTAATACAAACGTTTCTATTAAAACAGCTCGTGATATTGTTTACATATTACAAAACCACTATCCAGAAAGGCTTGCTATTGCCTTTCTGTACAATCCTCCTAGAATATTTCAGGCTTTCTGGAAGGCCATCAAATACTTCCTGGATCCCAAGACAGTCCAGAAGGTCAAGTTTGTTTATCCTAATAACAAGGAAAGTGTGGAGCTGATGAAATCACTCTTCGACCTAGATAACCTTCCAAGTGAATTTGGGGGAAAAGCAACTTTAAAGTATGACCATGAAGAGTTCTCACAGTTGATGGCTGAGGATGATGTGAAAACTGCCAAGTTCTGGGGACTTGATGAGAAGCCCATCAATACTAAGAAAGGGCATTCTGTGGCAGAGGTGGCACCGGAACCTGTAGCTGTTCAGCCAGTTAGTTGA | 885 | 0.4305 | MFLLRRQSQNQQENDSSYQDTKVAELRAALGPLSGRRLKYCTDACLRRYLEARNWNVDKAKKMLEETLKWRSTYKPEEIQWAEVAHEGETGKVSRANFHDRLGRTVLIMRPGMQNTASAENNIRHLVYLLENAVLNLSEGQEQMSWLIDFTGFTLNTNVSIKTARDIVYILQNHYPERLAIAFLYNPPRIFQAFWKAIKYFLDPKTVQKVKFVYPNNKESVELMKSLFDLDNLPSEFGGKATLKYDHEEFSQLMAEDDVKTAKFWGLDEKPINTKKGHSVAEVAPEPVAVQPVS* | 295 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Apr3g0276 | 294 | CDD | SEC14 | 99 | 240 | IPR001251 | - | |
| Apr3g0276 | 294 | SUPERFAMILY | CRAL/TRIO domain | 82 | 256 | IPR036865 | - | |
| Apr3g0276 | 294 | MobiDBLite | consensus disorder prediction | 1 | 20 | - | - | |
| Apr3g0276 | 294 | PANTHER | GH16843P | 6 | 291 | - | - | |
| Apr3g0276 | 294 | Gene3D | - | 3 | 279 | IPR036865 | - | |
| Apr3g0276 | 294 | PANTHER | DIVERGENT CRAL/TRIO DOMAIN PROTEIN | 6 | 291 | - | - | |
| Apr3g0276 | 294 | Pfam | CRAL/TRIO domain | 98 | 239 | IPR001251 | - | |
| Apr3g0276 | 294 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 81 | 245 | IPR001251 | - | |
| Apr3g0276 | 294 | SMART | CRAL_TRIO_N_2 | 42 | 67 | IPR011074 | - | |
| Apr3g0276 | 294 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 10 | 82 | IPR036273 | - | |
| Apr3g0276 | 294 | SMART | sec14_4 | 87 | 242 | IPR001251 | - | |
| Apr3g0276 | 294 | PRINTS | Cellular retinaldehyde-binding protein signature | 45 | 67 | - | - | |
| Apr3g0276 | 294 | PRINTS | Cellular retinaldehyde-binding protein signature | 162 | 183 | - | - | |
| Apr3g0276 | 294 | PRINTS | Cellular retinaldehyde-binding protein signature | 231 | 240 | - | - | |
| Apr3g0276 | 294 | Pfam | CRAL/TRIO, N-terminal domain | 42 | 66 | IPR011074 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Apr3g0276 | Apr-Chr3 | 5421530 | 5425064 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Apr3g0276 | 46 | 234 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 28.293 | 6.37e-12 | 63.2 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Apr3g0276 | - | - | gmx:100800024 | 515.383 |